News.

8 July 2022

Understanding the AI-enabled Drug Discovery Landscape

An Expert View from Henrietta Bull, science and partnership analyst, and Robert Thong, chief executive, MultiOmic Health.

AI Drug Discovery Multiomic Health The Pharma Letter

1 July 2022

Interview, Podcast

The Pharma Letter Podcast — Episode 15 — Can AI find new drugs for metabolic diseases?

In this week’s episode of The Pharma Letter Podcast, MultiOmic chief executive Robert Thong discusses his firm’s progress and ambitions for the future.

AI Multiomic Health Podcast Robert Thong The Pharma Letter

30 June 2022

MultiOmic Health and Mesh Bio Partner to Use AI to Develop Precision Medicines and Diagnostics for Chronic Metabolic Disease

MultiOmic Health and Mesh Bio announce their partnership to conduct an observational clinical study on patients with chronic metabolic disease.

Mesh Bio Multiomic Health Partnership Press Release

11 April 2022

Leveraging deep omics data to tackle a global health challenge with precision

We are excited to announce our feature in the most recent edition of Nature Portfolio’s Biopharma Dealmakers discussing the advances in AI-driven drug development.

Feature MOHSAIC Nature Omics Precision Medicine

14/14

COPYRIGHT notice

All the content on multiomic.health is either self-generated by Multiomic Health Limited, or readily available in various places on the Internet and therefore believed to be in the public domain. Transparent PNG images uploaded are believed to be posted within our rights according to the U.S. Copyright Fair Use Act (Title 17, U.S. Code.) and comparable regulations in other countries.

multiomic.health complies with 17 U.S.C. 512 and the Digital Millennium Copyright Act (“DMCA”). It is our policy to respond to any infringement notices and take appropriate actions under the DMCA and other applicable intellectual property laws.

If by any chance your copyrighted material has been posted on multiomic.health or if links to your copyrighted material are returned through a search engine and you wish this material removed, please provide a written statement identifying in sufficient detail the copyrighted work claimed to have been infringed. You may use the contact form at the end of the landing page for the purposes of such written communication.

DATA SOURCES

https://ourworldindata.org/causes-of-death

https://ourworldindata.org/obesity

https://bmjopen.bmj.com/content/10/8/e036663

How Prevalent is NASH?

https://www.heart.org/-/media/phd-files-2/science-news/2/2021-heart-and-stroke-stat-update/2021_heart_disease_and_stroke_statistics_update_fact_sheet_at_a_glance.pdf?la=en

https://www.ahajournals.org/doi/10.1161/CIR.0000000000000757

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278808/

https://www.cdc.gov/obesity/data/adult.html

https://stop.publichealth.gwu.edu/sites/stop.publichealth.gwu.edu/files/documents/Fast%20Facts%20Cost%20of%20Obesity.pdf

https://www.sciencedirect.com/science/article/abs/pii/S2211883717300187

https://journals.lww.com/jcge/Abstract/2015/09000/The_Epidemiology_of_Cirrhosis_in_the_United.12.aspx#:~:text=The%20prevalence%20of%20cirrhosis%20in%20the%20United%20States%20was%20approximately,unaware%20of%20having%20liver%20disease

How Prevalent is NASH?

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743497/#:~:text=In%20the%20United%20States%2C%20NAFLD,nearly%2025%25%20progress%20to%20NASH

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767767/

https://www.nature.com/articles/nrgastro.2017.109

https://www.diabetes.org/resources/statistics/statistics-about-diabetes#:~:text=Prevalence%3A%20In%202018%2C%2034.2%20million,of%20the%20population%2C%20had%20diabetes.&text=Undiagnosed%3A%20Of%20the%2034.2%20million,and%207.3%20million%20were%20undiagnos

https://www.kcl.ac.uk/news/spotlight/global-cost-of-diabetes-set-to-double-by-2030

https://www.kcl.ac.uk/news/spotlight/global-cost-of-diabetes-set-to-double-by-2030

https://www.worldobesity.org/news/world-obesity-day-all-countries-significantly-off-track-to-meet-2025-who-targets-on-obesity